A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada

by Georgie Weston, Caroline Dombrowski, Marc Steben, Catherine Popadiuk, James Bentley, Elisabeth J. Adams
Published 2021-09-01

Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economi...

by Maria Kyrgiou, Christina Founta, Georgie Weston, Caroline Dombrowski, Michael J Harvey, Thomas Iftner, Elisabeth J Adams
Published 2020-03-01